Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis
T Lv, S Chen, M Li, D Zhang, Y Kong… - … of gastroenterology and …, 2021 - Wiley Online Library
Abstract Background and Aim We aimed to estimate the worldwide incidence and
prevalence, with focus on the geographical differences and temporal trends. Methods …
prevalence, with focus on the geographical differences and temporal trends. Methods …
Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis
N Zeng, W Duan, S Chen, S Wu, H Ma, X Ou… - Hepatology …, 2019 - Springer
Aims Epidemiological studies on primary biliary cholangitis (PBC) show heterogeneity. The
aim of the present study was to synthesize the prevalence, incidence and clinical course of …
aim of the present study was to synthesize the prevalence, incidence and clinical course of …
Increase trend in the prevalence and male‐to‐female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan
A Tanaka, M Mori, K Matsumoto, H Ohira… - Hepatology …, 2019 - Wiley Online Library
Aim Autoimmune liver diseases (AILD) including autoimmune hepatitis (AIH), primary biliary
cholangitis (PBC), and primary sclerosing cholangitis (PSC) impose a significant burden on …
cholangitis (PBC), and primary sclerosing cholangitis (PSC) impose a significant burden on …
Contemporary epidemiology of primary biliary cholangitis
F Colapietro, A Bertazzoni, A Lleo - Clinics in Liver Disease, 2022 - liver.theclinics.com
Primary biliary cholangitis (PBC) is an immune-mediated cholestatic liver disease mainly
diagnosed in middle-aged women, with a female-to-male ratio between 4 to 5: 1 and 9 to 10 …
diagnosed in middle-aged women, with a female-to-male ratio between 4 to 5: 1 and 9 to 10 …
[PDF][PDF] Real‐world effectiveness of obeticholic acid in patients with primary biliary cholangitis
SB Roberts, M Ismail, G Kanagalingam… - Hepatology …, 2020 - Wiley Online Library
Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic
acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) …
acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) …
pathophysiology and management of primary biliary cholangitis
Background Primary biliary cholangitis (PBC), an immune‐mediated disease characterised
by destruction of intrahepatic bile ducts, results in progressive damage to the biliary tree …
by destruction of intrahepatic bile ducts, results in progressive damage to the biliary tree …
[HTML][HTML] Linking Human Betaretrovirus with autoimmunity and liver disease in patients with primary biliary cholangitis
H Syed, T Penner, AL Mason - Viruses, 2022 - mdpi.com
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by the
production of diagnostic antimitochondrial antibodies (AMA) reactive to the pyruvate …
production of diagnostic antimitochondrial antibodies (AMA) reactive to the pyruvate …
Race/ethnicity and insurance-specific disparities in in-hospital mortality among adults with primary biliary cholangitis: analysis of 2007–2014 national inpatient sample
A Galoosian, C Hanlon, M Tana, R Cheung… - Digestive Diseases and …, 2020 - Springer
Background Primary biliary cholangitis (PBC) is a progressive autoimmune liver disease that
can result in cirrhosis and end-stage liver disease. Aims We aim to evaluate hospitalization …
can result in cirrhosis and end-stage liver disease. Aims We aim to evaluate hospitalization …
A population-based characterization study of anti-mitochondrial M2 antibodies and its consistency with anti-mitochondrial antibodies
E Liang, M Liu, P Ke, G Han, C Zhang… - Laboratory …, 2023 - academic.oup.com
Objective This study aims to estimate the prevalence of anti-mitochondrial antibody subtype
M2 (AMA-M2) and assess its consistency with AMA in a general population. Methods A total …
M2 (AMA-M2) and assess its consistency with AMA in a general population. Methods A total …
Clinical characterization of patients with primary biliary cholangitis: A report from multiple Canadian centres
EM Yoshida, MG Swain, C Tsien… - Canadian Liver …, 2022 - canlivj.utpjournals.press
BACKGROUND: Primary biliary cholangitis (PBC) is a rare, chronic autoimmune, cholestatic
liver disease affecting approximately 318 per million Canadians. There is limited information …
liver disease affecting approximately 318 per million Canadians. There is limited information …